Company intelligence
IBA
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered to be the most advanced form of radiation therapy available today, industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
Verified activity
Signals from IBA
6 published signals
Partnerships
IBA contributed to the NEXUS project alongside Université libre de Bruxelles, Vrije Universiteit Brussel and Elysia-Raytest to advance the development of innovative Astatine-211 based targeted alpha therapies
Reported by IBA
Presence & Recognition
IBA colleagues visited Maison Mieux-Être to discover their inspiring work and initiatives supporting cancer care.
Reported by IBA
Presence & Recognition
IBA participated in PFAROS, a new European research and innovation initiative launched to address environmental emissions and exposure concerns related to per- and polyfluoroalkyl substances (PFAS) in the pharmaceutical and medical sectors.
Reported by IBA
Presence & Recognition
IBA brought its expertise to the fight against PFAS pollution.
Reported by Audrey Zwings
Partnerships
IBA partnered with the Connecticut Proton Center team on the official opening of the Connecticut Proton Center.
Reported by Ali Onuralp
Presence & Recognition
IBA is hosting a guided tour of its Louvain-la-Neuve site on October 4 as part of the Journée Découverte Entreprises event.
Reported by IBA